Kensuke Kojima

5.0k total citations
135 papers, 2.9k citations indexed

About

Kensuke Kojima is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Kensuke Kojima has authored 135 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hematology, 59 papers in Molecular Biology and 52 papers in Oncology. Recurrent topics in Kensuke Kojima's work include Acute Myeloid Leukemia Research (38 papers), Cancer-related Molecular Pathways (29 papers) and Lymphoma Diagnosis and Treatment (18 papers). Kensuke Kojima is often cited by papers focused on Acute Myeloid Leukemia Research (38 papers), Cancer-related Molecular Pathways (29 papers) and Lymphoma Diagnosis and Treatment (18 papers). Kensuke Kojima collaborates with scholars based in Japan, United States and Germany. Kensuke Kojima's co-authors include Michael Andreeff, Marina Konopleva, Vivian Ruvolo, Teresa McQueen, Ismael Samudio, Jo Ishizawa, Twee Tsao, Masato Shikami, Shinya Kimura and Yoko Tabe and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Kensuke Kojima

129 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kensuke Kojima Japan 29 1.8k 1.1k 959 444 327 135 2.9k
Virginie Penard‐Lacronique France 23 1.4k 0.8× 829 0.8× 977 1.0× 592 1.3× 573 1.8× 44 2.8k
Amanda L. Christie United States 21 1.6k 0.9× 1.0k 0.9× 624 0.7× 257 0.6× 275 0.8× 34 2.4k
Renate Burger Germany 27 1.6k 0.9× 1.1k 1.0× 990 1.0× 221 0.5× 628 1.9× 66 2.9k
Rose Ann Padua United Kingdom 32 1.6k 0.9× 926 0.9× 1.2k 1.3× 464 1.0× 480 1.5× 104 3.1k
Fumihiko Hayakawa Japan 26 1.4k 0.8× 624 0.6× 1.1k 1.1× 430 1.0× 303 0.9× 85 2.4k
Anupama Narla United States 22 3.0k 1.7× 738 0.7× 1.1k 1.2× 459 1.0× 425 1.3× 53 3.9k
Yosef Landesman United States 33 2.5k 1.4× 935 0.9× 640 0.7× 207 0.5× 232 0.7× 171 3.2k
Miron Prokocimer Israel 22 1.2k 0.7× 860 0.8× 551 0.6× 342 0.8× 217 0.7× 60 2.3k
Jianguo Tao United States 25 1.8k 1.0× 642 0.6× 564 0.6× 347 0.8× 617 1.9× 76 2.8k
Christine Pien United States 14 2.8k 1.6× 1.5k 1.4× 1.3k 1.4× 298 0.7× 331 1.0× 23 3.7k

Countries citing papers authored by Kensuke Kojima

Since Specialization
Citations

This map shows the geographic impact of Kensuke Kojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensuke Kojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensuke Kojima more than expected).

Fields of papers citing papers by Kensuke Kojima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensuke Kojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensuke Kojima. The network helps show where Kensuke Kojima may publish in the future.

Co-authorship network of co-authors of Kensuke Kojima

This figure shows the co-authorship network connecting the top 25 collaborators of Kensuke Kojima. A scholar is included among the top collaborators of Kensuke Kojima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensuke Kojima. Kensuke Kojima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishida, Yuki, Ran Zhao, Lauren Heese, et al.. (2021). Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML. Leukemia. 35(9). 2469–2481. 25 indexed citations
2.
3.
Ando, Toshihiko, Masako Yokoo, Hiroo Katsuya, et al.. (2020). Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor. International Journal of Hematology. 112(2). 249–253. 3 indexed citations
4.
Ishizawa, Jo, Kenji Nakamaru, Takahiko Seki, et al.. (2018). Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition. Cancer Research. 78(10). 2721–2731. 44 indexed citations
5.
Fukushima, Noriyasu, Masako Yokoo, Takero Shindo, et al.. (2018). Monitoring of citrulline and diamine oxidase levels as biomarkers for intestinal mucositis during early-phase hematopoietic cell transplantation. PubMed Central. 1(1). 1 indexed citations
6.
Ureshino, Hiroshi, Hidekazu Itamura, Mariko Yoshimura, et al.. (2018). Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma. Annals of Hematology. 98(2). 465–471. 22 indexed citations
7.
Cao, Liangxian, Arthur Branstrom, John D. Baird, et al.. (2017). PTC299 Is a Novel DHODH Inhibitor That Modulates VEGFA mRNA Translation and Inhibits Proliferation of a Broad Range of Leukemia Cells. Blood. 130. 1371–1371. 1 indexed citations
8.
Nishida, Yuki, Shinya Kimura, Kensuke Kojima, et al.. (2017). Automatic digital quantification of bone marrow myeloma volume in appendicular skeletons - clinical implications and prognostic significance. Scientific Reports. 7(1). 12885–12885. 7 indexed citations
9.
Itamura, Hidekazu, Yasushi Kubota, Takero Shindo, et al.. (2017). Elderly Patients With Chronic Myeloid Leukemia Benefit From a Dasatinib Dose as Low as 20 mg. Clinical Lymphoma Myeloma & Leukemia. 17(6). 370–374. 15 indexed citations
10.
Ishizawa, Jo, Kensuke Kojima, Teresa McQueen, et al.. (2015). Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs. PLoS ONE. 10(9). e0138377–e0138377. 21 indexed citations
11.
Kojima, Kensuke, Seshagiri Duvvuri, Vivian Ruvolo, et al.. (2011). Decreased sensitivity of 17p‐deleted chronic lymphocytic leukemia cells to a small molecule BCL‐2 antagonist ABT‐737. Cancer. 118(4). 1023–1031. 19 indexed citations
12.
Kojima, Kensuke, Jared K. Burks, Janine Arts, & Michael Andreeff. (2010). The Novel Tryptamine Derivative JNJ-26854165 Induces Wild-Type p53- and E2F1-Mediated Apoptosis in Acute Myeloid and Lymphoid Leukemias. Molecular Cancer Therapeutics. 9(9). 2545–2557. 67 indexed citations
13.
Jin, Linhua, Yoko Tabe, Kensuke Kojima, et al.. (2010). MDM2 antagonist Nutlin-3 enhances bortezomib-mediated mitochondrial apoptosis in TP53-mutated mantle cell lymphoma. Cancer Letters. 299(2). 161–170. 33 indexed citations
14.
Kojima, Kensuke, et al.. (2009). Cyclin‐dependent kinase 1 inhibitor RO‐3306 enhances p53‐mediated Bax activation and mitochondrial apoptosis in AML. Cancer Science. 100(6). 1128–1136. 38 indexed citations
15.
16.
Kojima, Kensuke, Nobuharu Fujii, Daigo Hashimoto, et al.. (2003). Successful treatment with cyclosporin A of myelodysplastic syndrome with erythroid hypoplasia associated with t(6;8)(q15;q22). Cancer Genetics and Cytogenetics. 140(2). 167–169. 3 indexed citations
17.
Yoshida, Chie, et al.. (2002). Fournier's gangrene after unrelated cord blood stem cell transplantation. Annals of Hematology. 81(9). 538–539. 9 indexed citations
18.
Sugimoto, Tohru, Shion Imoto, Yoshinobu Matsuo, et al.. (2001). T-cell receptor γδ T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype. Annals of Hematology. 80(12). 749–751. 20 indexed citations
19.
Kojima, Kensuke, Akiko Masuda, Hiromichi Dansako, et al.. (2001). Therapy-related myelodysplastic syndrome/acute myeloid leukemia M2 and translocation (8;21). Annals of Hematology. 80(12). 763–766. 5 indexed citations
20.
Maeda, Yoshinobu, Takanori Teshima, Masao Yamada, et al.. (1999). Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation. British Journal of Haematology. 105(1). 295–302. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginie Penard‐Lacronique Breakdown of academic impact, for papers by Amanda L. Christie Breakdown of academic impact, for papers by Renate Burger Breakdown of academic impact, for papers by Rose Ann Padua Breakdown of academic impact, for papers by Fumihiko Hayakawa Breakdown of academic impact, for papers by Anupama Narla Breakdown of academic impact, for papers by Yosef Landesman Breakdown of academic impact, for papers by Miron Prokocimer Breakdown of academic impact, for papers by Jianguo Tao Breakdown of academic impact, for papers by Christine Pien
Rankless by CCL
2026